Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Long-Term Debt Repayments (2016)

Medifast (MED) has disclosed Long-Term Debt Repayments for 7 consecutive years, with $56000.0 as the latest value for Q4 2016.

  • For the quarter ending Q4 2016, Long-Term Debt Repayments fell 31.71% year-over-year to $56000.0, compared with a TTM value of $219000.0 through Dec 2016, down 14.12%, and an annual FY2016 reading of $219000.0, down 14.12% over the prior year.
  • Long-Term Debt Repayments was $56000.0 for Q4 2016 at Medifast, up from $55000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $3.4 million in Q1 2013 and bottomed at $53000.0 in Q1 2016.
  • Average Long-Term Debt Repayments over 5 years is $289050.0, with a median of $57500.0 recorded in 2015.
  • The sharpest move saw Long-Term Debt Repayments soared 1167.04% in 2013, then crashed 98.39% in 2014.
  • Year by year, Long-Term Debt Repayments stood at $147000.0 in 2012, then plummeted by 63.27% to $54000.0 in 2013, then grew by 3.7% to $56000.0 in 2014, then soared by 46.43% to $82000.0 in 2015, then plummeted by 31.71% to $56000.0 in 2016.
  • Business Quant data shows Long-Term Debt Repayments for MED at $56000.0 in Q4 2016, $55000.0 in Q3 2016, and $55000.0 in Q2 2016.